GDC-0339

CAT: 0804-HY-16976-01Size: 5 mgDry Ice: NoHazardous: No
CAT#:0804-HY-16976-01Size:5 mg
Selected
PRICE
AVAILABILITY: InStock
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Product image 1
1 / 1
Description
GDC-0339 is a potent, orally bioavailable and well tolerated pan-Pim kinase inhibitor, with Kis of 0.03 nM, 0.1 nM and 0.02 nM for Pim1, Pim2 and Pim3, respectively. GDC-0339 is discovered as a potential treatment of multiple myeloma[1][2].
CAS Number
[1428569-85-0]
UNSPSC
12352005
Target
Pim
Type
Reference compound
Related Pathways
JAK/STAT Signaling
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/GDC-0339.html
Concentration
10mM
Purity
99.87
Solubility
DMSO : ≥ 52 mg/mL
Smiles
FC1=CC=CC(F)=C1C2=NC(C(NC3=C(N4CC[C@@H](F)[C@H](N)CC4)N(C)N=C3)=O)=C(N)S2
Molecular Formula
C20H22F3N7OS
Molecular Weight
465.50
References & Citations
[1]Takahashi RH, et al. CYP1A1-Mediated Intramolecular Rearrangement of Aminoazepane in GDC-0339. Drug Metab Dispos. 2017 Oct;45 (10) :1084-1092.|[2]Wang X, et al. Optimization of Pan-Pim Kinase Activity and Oral Bioavailability Leading to Diaminopyrazole (GDC-0339) for the Treatment of Multiple Myeloma. J Med Chem. 2019 Feb 28;62 (4) :2140-2153.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
PIM1; PIM2; PIM3

Related Products

CatalogName
HY-115877-01GDC-0334
HY-19926-01GDC-0425
HY-101272-01GDC-0326
HY-160851-01GDC-3280
HY-171193GDC-0570
HY-50864-01GDC-0879
HY-15427-01GDC-0834
HY-156751A-01GDC-2992
HY-148258-01GDC-2394
HY-111484-01GDC-0927

Alternative Products

CatalogName
MBS131137-01GDC-0339
A20920-10GDC-0339 10mg
A20920-100GDC-0339 100mg
A20920-5GDC-0339 5mg
A20920-25GDC-0339 25mg
A20920-50GDC-0339 50mg
A20920-2GDC-0339 2mg
60B981GDC
MBS131624-01GDC-0326 ?GDC0326? GDC 0326?
MBS3606501-01GDC-0879

Popular Products